Verdinexor
Verdinexor (KPT-335) is an orally bioavailable, selective inhibitor of the nuclear export protein XPO1/CRM1. It is utilized in preclinical research to study oncology, virology, and inflammation, demonstrating activity in both cellular assays and animal models of cancer and viral infection.
Product Specifications
CAS Number
1392136-43-4
Product Name Alternative
CRM1, KPT335, KPT-335, KPT 335, Verdinexor
Field of Research
Cell Biology, Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:82 mg/mL (185.39 mM) ; Ethanol:9 mg/mL (20.35 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.46 mM)
Smiles
FC (F) (F) c1cc (cc (c1) C (F) (F) F) -c1ncn (\C=C/C (=O) NNc2ccccn2) n1
Molecular Formula
C18H12F6N6O
Molecular Weight
442.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TA804746AM 100 µL
VE Cadherin (CDH5) Mouse Monoclonal Antibody (Biotin conjugated) [Clone ID: OTI1F4]
Sign In for Pricing
View Details 
sc-393931 AF647 200 µg/mL
20S Proteasome β5 (A-10) Alexa Fluor® 647
Sign In for Pricing
View Details NB100-555AF532 0.1 mL
Rabbit Polyclonal HR6A/UBE2A Antibody [Alexa Fluor 532]
Sign In for Pricing
View Details